Indonesia vs Myanmar: Proportion of bloodstream infection due to methicillin-resistant
Indonesia
40.1%
in 2023
Myanmar
40.0%
in 2023
Indonesia rank
21st
Myanmar rank
22nd
Proportion of bloodstream infection due to methicillin-resistant over time
- Indonesia
- Myanmar
How they compare
Indonesia currently reports 40.1% against 40.0% in Myanmar, a difference of 0.1%.
The two have swapped places 1 time across 5 shared years of data; in 2018 it was Myanmar ahead.
Indonesia ranks 21st and Myanmar ranks 22nd of 55 countries.
Myanmar has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 46.1% | 64.9% | 18.8% | Myanmar |
| 2020s | 37.2% | 52.5% | 15.4% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Indonesia or Myanmar?
- Indonesia, at 40.1% against 40.0% in Myanmar as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Indonesia and Myanmar?
- 0.1%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Myanmar?
- 5 years are reported by both, from 2018 to 2023.
- How do Indonesia and Myanmar rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Indonesia ranks 21st and Myanmar ranks 22nd of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.